The Wall Street Journal reports a unit of China’s Fosun Group has agreed to buy a controlling stake, roughly 86%, in Indian pharmaceutical company Gland Pharma Ltd. from shareholders including KKR & Co. for up to $1.26 billion. The deal is China’s largest takeover of a company in India. The largest Chinese deal maker in […]
Category: Health Care
Venture capitalists are now betting that the Chinese Communist Party’s decision to repeal its decades-old one-child policy will create more demand for digital services related to pregnancy and childcare, Bloomberg reports. The policy change announced last year has piqued investor interest and led to 10 fundraising rounds in the first half for startups in the maternity and […]
China Resources Group is leading a consortium poised to acquire a stake in Australian cancer therapy provider Genesis Care, the first big health-care deal following last year’s free-trade agreement between the two countries, The Wall Street Journal reports. China Resources, one of the country’s biggest conglomerates, has teamed up with Australian investment bank Macquarie Group […]
As China’s medical bills rise steeply, outpacing government insurance provision, patients and their families are increasingly turning to loans to pay for healthcare, adding to the country’s growing burden of consumer debt. Reuters reports that while public health insurance reaches nearly all of China’s 1.4 billion people, its coverage is basic, leaving patients liable for […]
Pfizer will invest $350 million to build a biotech center in China, the latest in a series of moves by pharma industry giants to set up shop in the world’s no. 2 drugs market with the aim of securing faster approvals for their products. Reuters reports the facility in eastern Hangzhou region – Pfizer’s first […]